News Search Results
Aug 25, 2025, 06:19 ET Acceleration in Clinical Development! Leads Biolabs' LBL-034 Dosed First Patient in Phase Ⅱ Trial
MM in October 2024. About Leads Biolabs Founded in 2012, Leads Biolabs is a clinical-stage biotechnology company dedicated to the discovery, development, and commercialization of innovative therapies to address underserved medical needs in oncology,
More news about: Leads Biolabs
Aug 25, 2025, 06:00 ET IDEAYA Biosciences to Participate in Upcoming September 2025 Investor Relations Events
9:10 AM ET Fireside chat with Yujiro S. Hata, President and Chief Executive Officer, hosted by Li Watsek, Director, Biotechnology AnalystIDEAYA Biosciences 10-Year Anniversary R&D DayMonday, September 8th, 2025
More news about: IDEAYA Biosciences, Inc.
Aug 23, 2025, 10:45 ET Targeted Protein Degradation Market worth $9.85 billion by 2035 with 35.4% CAGR | MarketsandMarkets™
driven by strong R&D infrastructure, robust funding ecosystems, and a favorable regulatory environment. The region is home to several pioneering biotechnology and pharmaceutical companies that are leading the development of TPD platforms, particularly PROTACs and molecular glues. Major players such as
More news about: MarketsandMarkets
Aug 23, 2025, 10:01 ET Biobanking Market worth $11.82 billion by 2030 with 9.1% CAGR | MarketsandMarkets™
By end users, the biobanking services market is segmented into pharmaceutical & biotechnology companies & CROs, and academic & research institutes. The pharmaceutical & biotechnology companies & CROs segment is estimated to register the highest growth rate during the forecast
More news about: MarketsandMarkets
Aug 22, 2025, 16:00 ET Innocan's Findings to be Showcased in Scientific Poster Reception at PAINWeek 2025 Conference in Las Vegas, Nevada
/CNW/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) ("Innocan" or the "Company"), a pioneer in the pharmaceutical and biotechnology industries, proudly announces that during the PAINWeek conference 2025, it will showcase a poster outlining key data on LPT-CBD pharmacokinetics
More news about: Innocan Pharma Corporation
Aug 22, 2025, 16:00 ET Innocan's Findings to be Showcased in Scientific Poster Reception at PAINWeek 2025 Conference in Las Vegas, Nevada
/PRNewswire/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) ("Innocan" or the "Company"), a pioneer in the pharmaceutical and biotechnology industries, proudly announces that during the PAINWeek conference 2025, it will showcase a poster outlining key data on LPT-CBD pharmacokinetics
More news about: Innocan Pharma Corporation
Aug 22, 2025, 13:54 ET 6 Panitch Schwarze Lawyers Named Among 2026 'Best Lawyers,' 'Ones to Watch'
fields, and Wieland on the electronics, software, and manufacturing sectors. Ejimonyeugwo focuses on life sciences, pharmaceuticals, software, biotechnology, and engineering, and Lutz assists clients with counseling and opinions relating to life sciences IP. Since it was first published in 1983,
More news about: Panitch Schwarze Belisario & Nadel LLP
Aug 22, 2025, 10:45 ET Ethanol Market Size Will Reach US$162.7 Billion by 2032 as Clean Energy Policies, Biofuel Innovation, and Decarbonization Drive Unprecedented Growth | According to DataM Intelligence
India are leveraging sugarcane, corn, and by-products to expand ethanol production. At the same time, investments in biotechnology and efficient processing techniques are enhancing yields and improving sustainability. Advanced production methods, including cellulosic
More news about: DataM Intelligence 4 Market Research LLP
Aug 22, 2025, 10:01 ET Epigenetics Market is expected to generate a revenue of USD 3.70 Billion by 2031, Globally, at 13.94% CAGR: Verified Market Research®
data.Applications in oncology, neurology, and cardiovascular diseases are fueling demand for advanced epigenetic platforms.Pharmaceutical and biotechnology firms are channeling heavy investments into epigenetic research to enhance personalized therapies.Growing awareness among clinicians and
More news about: Verified Market Research
Aug 22, 2025, 10:01 ET Walking Aids Market to Register 7.2% CAGR to Reach US$29.31 Billion by 2031 | The Insight Partners
syndicated and consulting research services. We specialize in semiconductor and electronics, aerospace and defense, automotive and transportation, biotechnology, healthcare IT, manufacturing and construction, medical devices, technology, media and telecommunications, and chemicals and materials. Contact
More news about: The Insight Partners
Aug 22, 2025, 10:00 ET Pomerantz Law Firm Announces the Filing of a Class Action Against Unicycive Therapeutics, Inc. and Certain Officers - UNCY
[Click here for information about joining the class action] Unicycive is a clinical-stage biotechnology company that identifies, develops, and commercializes therapies to address unmet medical needs in the U.S. The Company is developing, among other
More news about: Pomerantz LLP
Aug 22, 2025, 09:00 ET Lilly to participate in Wells Fargo 20th Annual Healthcare Conference
life-changing discoveries for nearly 150 years, and today our medicines help tens of millions of people across the globe. Harnessing the power of biotechnology, chemistry and genetic medicine, our scientists are urgently advancing new discoveries to solve some of the world's most significant health challenges:
More news about: Eli Lilly and Company
Aug 22, 2025, 08:00 ET WINVEST GROUP SUBSIDIARY IQI MEDIA PARTNERS WITH BIOCALTH TO DRIVE DIRECT-TO-CONSUMER SALES
future growth, ensuring both healthy development and steady progress. We intend to bolster our standing as a GMP manufacturer that sets the bar in biotechnology production." About IQI Media: Headquartered in Los Angeles, California, IQI Media Inc. is
More news about: Winvest Group Ltd
Aug 21, 2025, 13:43 ET Rubin and Rudman Adds Dawn Stolfi Stalenhoef as a Partner in Environmental, Land Use & Zoning Practice Group
Rubin and Rudman serves national and international companies, including large public companies and closely held businesses; real estate developers; biotechnology, pharmaceutical and medical device makers; regulated industries, public entities and municipalities; insurance companies and their insureds; educational
More news about: Rubin and Rudman
Aug 21, 2025, 13:30 ET Paragon Therapeutics Expands Executive Team to Advance Strategic Objectives
WALTHAM, Mass., Aug. 21, 2025 /PRNewswire/ -- Paragon Therapeutics, a biotechnology company that applies cutting-edge science and technology to design the next generation of best-in-class complex biologics for major medical needs,
More news about: Paragon Therapeutics
Aug 21, 2025, 12:45 ET Harnessing the Power of Laboratory Data to Optimize Trial Design, Site Identification and Patient Recruitment, Upcoming Webinar Hosted by Xtalks
the global life science, food, healthcare and medical device communities. Every year, thousands of industry practitioners (from pharmaceutical, biotechnology, food, healthcare and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access
More news about: Xtalks
Aug 21, 2025, 12:44 ET STAT Announces 2025 Rankings of Biotech's Top Venture Capital Firms
groundbreaking health care innovations. These firms have been instrumental in funding startups and companies that are at the forefront of medical research, biotechnology, and digital health. The report comes as the biotech industry faces a series of existential questions and the National Institutes of Health
More news about: STAT
Aug 21, 2025, 12:30 ET Biomedical Polyurethane Technologies for Medical Device Innovation, Upcoming Webinar Hosted by Xtalks
the global life science, food, healthcare and medical device communities. Every year, thousands of industry practitioners (from pharmaceutical, biotechnology, food, healthcare and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access
More news about: Xtalks
Aug 21, 2025, 12:28 ET Rubin and Rudman Announces 30 Lawyers Selected for 2026 Best Lawyers in America
Rubin and Rudman serves national and international companies, including large public companies and closely held businesses; real estate developers; biotechnology, pharmaceutical and medical device makers; regulated industries, public entities and municipalities; insurance companies and their insureds; educational
More news about: Rubin and Rudman
Aug 21, 2025, 10:30 ET Disposable Surgical Gloves Market is Growing at 10.1% CAGR to Reach US$5.18 billion by 2031; Due to Rising Number of Surgical Procedures | The Insight Partners
syndicated and consulting research services. We specialize in semiconductor and electronics, aerospace and defense, automotive and transportation, biotechnology, healthcare IT, manufacturing and construction, medical devices, technology, media and telecommunications, and chemicals and materials. Contact
More news about: The Insight Partners
Aug 21, 2025, 10:01 ET Tangential Flow Filtration Market worth $3.20 billion by 2030 with 11.4% CAGR | MarketsandMarkets™
end users, the tangential flow filtration market is segmented into pharmaceutical & biotechnology companies, CMOs & CROs, and academic & research institutes. The pharmaceutical & biotechnology companies' segment is estimated to register the highest growth rate during the forecast period,
More news about: MarketsandMarkets
Aug 21, 2025, 10:01 ET Cystoscopy and Ureteroscopy Market is Growing at 6.9% CAGR to Reach US$729.30 million by 2031; Due to Increasing Prevalence of Urological Diseases | The Insight Partners
syndicated and consulting research services. We specialize in semiconductor and electronics, aerospace and defense, automotive and transportation, biotechnology, healthcare IT, manufacturing and construction, medical devices, technology, media and telecommunications, and chemicals and materials. Contact
More news about: The Insight Partners
Aug 21, 2025, 08:30 ET AI in Molecular Biology: Revolutionizing the Future of Biotech, Upcoming Webinar Hosted by Xtalks
The featured speaker will discuss how streamlined workflows with AI-driven platforms reduce development time and simplify research processes in biotechnology and life sciences. Attendees will learn how accelerated innovation facilitates breakthroughs in synthetic biology, drug discovery, gene therapy
More news about: Xtalks
Aug 21, 2025, 08:30 ET Multidomain Biologics: Bioanalytical Strategies and Insights, Upcoming Webinar Hosted by Xtalks
the global life science, food, healthcare and medical device communities. Every year, thousands of industry practitioners (from pharmaceutical, biotechnology, food, healthcare and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access
More news about: Xtalks
Aug 21, 2025, 08:30 ET Dan Kagan, Scientist.com President and COO, Named Among Top 25 BioTech and Life Sciences Executives of 2025 by The Healthcare Technology Report
and operational leadership, contributions to therapeutic innovation and platform development, and their ability to advance the broader field of biotechnology and life sciences. Scientist.com congratulates Dan Kagan and the other outstanding recipients for their exceptional
More news about: Scientist.com